We believe that understanding the interactions between HO-1 and SIRT1 in NAFLD and related hepatic fibrosis will lead to the development of new biomarkers and therapeutic strategies to fight hepatic dysfunction. This evidence concerns the gene SIRT1 and Hepatic fibrosis.